Filing Flows › Editas Medicine (EDIT) › Recalls, complaints & regulation
Editas Medicine (EDIT): clinical trials
Editas Medicine (EDIT) beyond its filings: 4 active clinical trials.
Editas Medicine's latest quarter
Editas Medicine, Q2 2026: revenue $11.9M (+232% year over year), operating margin -156.0%, net loss $18.2M, operating cash flow −$29.6M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Editas Medicine have?
4 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.